Introduction
============

B lymphoma Mo-MLV insertion region 1 (BMI1) belongs to the polycomb group (PcG) protein family, which are transcriptional repressors [@B1]. As a proto-oncogene, *Bmi1* is associated with the regulation of cell differentiation, and is expressed highly in stem cells and several types of malignant tumors. BMI1 also plays a role in proliferation and apoptosis of tumor cells, regulation of chromosome stability, and self-renewal capacity [@B2], [@B3]. Recent studies have shown that BMI1 is related to cancer stem cells among tissues and organs, including head-and-neck, digestive system, hematopoietic system, respiratory system, mammary gland, genitourinary system, and skin [@B4]-[@B6]. Mechanistic studies revealed that BMI1 deficiency affects premature senescence, which involves oxidative stress and ongoing DNA damage. BMI1 deficiency, through the INK4a/p16 (also known as cyclin dependent kinase inhibitor 2A) and INK4d/p19 (cyclin dependent kinase inhibitor 2D) signaling pathways, inhibits CyclinD1, cell dependent kinase (CDK)4/6, and p53, which causes cell cycle arrest, growth arrest, cell senescence, and apoptosis [@B7], [@B8]. Therefore, oxidative stress status and the resulting changes in a series of downstream molecules may be the core mechanism of the negative systemic effect and premature aging caused by BMI1 deficiency.

Oxidative stress plays an essential role in critical biological processes in human reproduction [@B9]. The phenotype of oxidative damage to the reproductive system is similar to that of reproduction aging, and with age, germ cells are particularly sensitive to oxidative stress. In addition, the imbalance between reactive oxygen species (ROS) and protective antioxidants affects the entire reproductive lifespan in males and females [@B10]. A previous study suggested that in normal follicle development, there is a certain amount of ROS; however, excessive ROS not only reduces the amount and quality of granulosa cells, but also influences the whole reproductive stage, even causing infertility [@B11]. This could reduce oocytes numbers and qualities, upregulate aging indicators, and eventually cause ovulated oocyte defects [@B12]. Oxidative stress could also affect spermatogenesis, sperm function, and the spermatogenic microenvironment, eventually causing infertility [@B13], [@B14]. Therefore, researchers are keen to determine the role of BMI1 in the reproductive system and whether it is regulated by oxidative stress.

In our previous studies, we observed that BMI1 is not only expressed in nervous tissue and bone tissue, but also in testes and ovaries. BMI1 deficiency caused infertility in male mice, accompanied by smaller testes, oligospermia, and sperm malformation [@B15]-[@B18]. Studies indicated that BMI1 deficiency reduces testosterone syntheses, increases oxidative stress and DNA damage, activates p16 and p19 signaling pathways, inhibits germ cell proliferation, and inducing germ cell apoptosis and sperm malformation in male fertility [@B19]. However, it is unclear whether BMI1 deficiency contributes to female infertility, and whether antioxidants could rescue female infertility in mice deficient in BMI1.

Therefore, in the present study, 3-week-old *Bmi1^-/-^* mice were randomly treated with or without N-acetylcysteine ​​(NAC) in their drinking water. After 4 weeks of treatment, alterations in DNA damage, cell proliferation, and cell cycle-related parameters were analyzed in the ovaries. This study aimed to clarify the role of BMI1 in sustaining female reproduction, and thus could reveal a potential and effective direction for clinical therapy of female infertility.

Materials and Methods
=====================

Animals
-------

The *Bmi1* heterozygote (*Bmi1*^+/-^) mice (129Ola/ FVB/N hybrid background) provided in this study had been backcrossed in the C57BL/6J background and mated to generate *Bmi1* homozygote (*Bmi1*^-/-^) and their wild-type (WT) littermates, which were genotyped using PCR, as described previously [@B19]. In this study, all the mice were housed and bred in the Experimental Animal Center in Nanjing Medical University. Animal use was approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (IACUC-1706001).

Vaginal cytology
----------------

To assess the time of pubertal initiation in *Bmi1*^-/-^ mice, we observed the vaginal opening time at 8:00 am, starting with 3-week-old mice. The estrous cycle also was determined using a sterile stick or swab to wipe the vaginal wall gently, which was then mounted on gelatinized slides. The characterization of the estrous cycle was analyzed according to a previous report [@B20].

Histological analysis
---------------------

Ovarian tissues were fixed in 4% formaldehyde solution at 4 ºC overnight. After dehydration, permeabilization, wax immersion, and embedding, 5-μm sections were cut, stained with hematoxylin-eosin, and examined by microscopy (Olympus CX31, Japan).

Electron microscopy analysis
----------------------------

Ovarian specimens were prefixed in glutaraldehyde and post-fixed in osmium acid solution. After dehydration in acetone and embedding in epoxy resin, ultrathin sections were cut and loaded on copper screens. These sections were stained with uranium acetate and lead citrate, and then examined by transmission electron microscopy (TEM; Tecnai G2 Spirit Bio TWIN, USA).

Immunohistochemical staining
----------------------------

Briefly, ovarian sections were deparaffinized, hydrated, and immersed in H~2~O~2~ in methanol (1:10) to inactivate endogenous peroxidase. Non-specific binding of antibodies was blocked by incubating tissues with 10% goat serum for 1 hour at room temperature. Tissues were then incubated with antibodies recognizing BMI1 (Abjent, USA), proliferating cell nuclear antigen (PCNA) (Abcam, USA), Caspase-3 (BD, USA), 8-Oxo-2\'-deoxyguanosine (8-OHdG) (Abcam, USA), phosphorylated H2A histone family member X (γ.H2AX) (CST, USA), or bromodeoxyuridine (BrdU) (CST, USA) overnight at 4 ºC. The sections were then rinsed in phosphate-buffered saline (PBS) and incubated with biotin-conjugated secondary antibodies for 1 hour at room temperature. After washing, the sections were incubated with Elite ABC (Vector, USA) for 1 hour at room temperature, and diaminobenzidine (DAB) (Vector, USA) until the desired stain intensity developed. Sections were counter-stained with hematoxylin, and analyzed under microscopy (Axioskop 2 plus; Zeiss, Germany).

Western blotting
----------------

Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer containing 10% phenylmethanesulfonylfluoride (PMSF). The solution was precipitated for 1 hour on ice, and then centrifuged for 15 min at 13000 ×*g*. The pellet was dissolved in loading buffer. The protein samples were then resolved through sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and the separated proteins were transferred to polyvinylidene difluoride (PVDF) membranes. After washing with PBS, the PVDF membranes were blocked with 5% skim milk solution, and then incubated with various primary antibodies at 4 ºC overnight. The antibodies used were those recognizing caspase-3 (BD, USA), B-cell CLL/ lymphoma 2 (BCL2) (Santa Cruz Biotechnology, USA), p16 (Santa Cruz Biotechnology, USA), p19 (Cell Signaling Technology, USA), p53 (Santa Cruz Biotechnology, USA), superoxide dismutase 1 (SOD1) (Abcam, USA), superoxide dismutase 2 (SOD2) (Navus, USA), and β-actin (Abcam, USA). The membranes were then incubated with horseradish peroxidase (HRP)-conjugated goat anti-mouse, rabbit anti-goat, or goat-anti rabbit antibodies (KPL, USA). Immunoreactive protein bands were visualized using the enhanced chemiluminescence (ECL) solution (Nanjing Jiancheng Bioengineering Institute, China) and quantified using Scion Image Beta 4.02 (Scion Corporation, NIH).

Real-time reverse transcription-PCR
-----------------------------------

Total RNA was isolated from cell pellets or cartilage using the TRIzol reagent (Sigma, Japan). For reverse transcription (RT), mRNA was used as the template for single stranded DNA synthesis. A commercial RT-kit (Vazyme, China) was used. The primer sequences (forward and reverse, respectively) were: mouse *Sod1* (5′-GGTGAACCAGTTGTGTTGTC-3′, 5′-CCGTCCTTTCCAGCAGTC-3′), mouse *Sod2* (5′-GACCTGCCTTACGACTATG-3′, 5′-GAAGAGCGACCTGAGTTG-3′), mouse *Gpx1* (glutathione peroxidase 1) (5′-CAATCAGTTCGGACACCAGGAG-3′, 5′ -TCTCACCATTCACTTCGCACTTC-3′), mouse *Gsr* (glutathione-disulfide reductase) (5′-GGATTGGCTGTGATGAGATG-3′, 5′-CTGAAGAGGTAGGATGAATGG-3′), mouse *Cat* (catalase) (5′-CAGGTGCGGACATTCTAC-3′, 5′-TTGCGTTCTTAGGCTTCTC-3′), and mouse *Txnrd1* (thioredoxin reductase 1) (5′-TCCCTCTCATCAGTTCTATGG-3′, 5′-ACTTGGTGGTTTGCTACGAC-3′). For real-time PCR, the single stranded DNA was used as template with specific primers for the different genes. A commercial kit (Vazyme, China) was used to detect mRNA expression.

Flow cytometry analysis
-----------------------

ROS production in ovaries was tested using diacetyldichlorofluorescein staining (DCFDA, Invitrogen, USA). Fresh ovaries were placed in PBS at 4 ºC, and then the single cell suspension was collected by squeezing the ovaries through gauze. DCFDA (5 mM) was added to the cells. After 30 min of incubation at 37 ºC, the cells were centrifuged at 2000 × *g* for 5 min and the pellet was washed with PBS twice. Finally, the samples were analyzed using flow cytometry with a FACS-calibur flow cytometer from Becton Dickinson (Germany).

N-acetylcysteine Supplementation
--------------------------------

For *in vivo* administration, *Bmi1*^-/-^ female mice were randomized to receive drinking water with or without NAC (1 mg×ml^-1^) for 4 weeks until they were 7 weeks old, which was based on previously published reports [@B7], [@B12] and our preliminary research.

Oocyte collection
-----------------

Mice were stimulated via intraperitoneal injection of 5 IU of pregnant mare serum gonadotropin (PMSG, Ningbo Sansheng, China). To retrieve ovulated oocytes, 46 hours later, mice were injected with 5 IU human chorionic gonadotropin (hCG, NingboSansheng, China). Fourteen hours later, cumulus-oocyte complexes were released by ampulla puncture. The cumulus masses were removed by incubation in hyaluronidase medium (Sigma, Aldrich).

*In vitro* fertilization and embryo culture
-------------------------------------------

Sperm was separated from the epididymis of 10-week-old male mice. After maintaining in human tubal fluid (HTF) (Shanghai, China) fertilization medium containing bovine serum albumin (BSA; Nanjing, China) for 1.5 hours, dispersed spermatozoa were added to HTF drops containing ovulated oocytes at 37 °C for 4 hours. The embryos were then transferred into potassium simplex optimization medium (KSOM) medium (Millipore, MR-020P-D, USA) and cultured to the blastocyst stage in 5% CO~2~ in air, and 95% relative humidity at 37 °C. Micrographs were then acquired under a stereoscope (Nikon, Burlingame, California, USA).

Statistical analysis
--------------------

All data from the image analyses are presented as the mean ± the standard error of the mean (SEM). Statistical analyses were performed using SPSS 16.0 (Version 16.0, SPSS Inc., Chicago, IL, USA). Statistical comparisons were evaluated using Student\'s test and two-way analysis of variance (ANOVA) when appropriate. Statistical significance was confirmed at *P* \< 0.05.

Results
=======

The localization of BMI1 in ovaries and the effects of BMI1 deficiency on the fertility and estrous cycle
---------------------------------------------------------------------------------------------------------

To identify the localization of BMI1 in ovaries, we performed immunohistochemical staining on ovarian sections of WT female mice using anti-BMI1 antibodies (Fig. [1](#F1){ref-type="fig"}A-B)*.* The results revealed that in female mice, BMI1 was expressed in granulosa cells, including both mural granulosa cells (GCs) and cumulus cells (CCs), and in theca cells and interstitial cells. To identify whether BMI1 was required to sustain female fertility, we crossed WT or *Bmi1*^-/-^ female mice with WT male mice in adulthood for 1 month. Compared with the WT female mice, *Bmi1*^-/-^ female mice were completely infertile (Fig. [1](#F1){ref-type="fig"}C). To evaluate the influence of BMI1 deficiency on ovulation, the WT and *Bmi1*^-/-^ mice received an injection with PMSG, and then hCG after 44 hours. The egg masses were taken out and counted from the ampulla portion after 16 hours. The results showed that BMI1 deficiency attenuated ovulation (Fig. [1](#F1){ref-type="fig"}D). Compared with that in WT female mice, the *Bmi1*^-/-^ mice vaginal opening time was markedly delayed (Fig. [1](#F1){ref-type="fig"}E). Estrous cycle dysfunction was also observed (Fig. [1](#F1){ref-type="fig"}F, 1I). In addition, the proestrus and estrus times were reduced significantly (Fig. [1](#F1){ref-type="fig"}G-H). In contrast, the diestrus and metestrus times were prolonged significantly (Fig. [1](#F1){ref-type="fig"}J-K).

BMI1 deficiency results in ovarian and follicular development defects in mice
-----------------------------------------------------------------------------

To explore whether the infertility in *Bmi1*^-/-^ mice contributed to defective ovarian and follicular development, we compared the ovarian weight, ovarian weight/body weight ratio, and each stage follicles between *Bmi1*^-/-^ and WT mice. We noted that the ovarian size, weight, and the total body weight ratio decreased dramatically in *Bmi1*^-/-^ mice compared with those in WT mice (Fig. [2](#F2){ref-type="fig"}A-C). To further clarify the changes in the amounts of follicles and their proportion among different stages, the numbers of primordial, primary, secondary, mature, and atretic follicles were assessed in serial ovarian H&E stained sections from 1-week, 4-week, and 7-week-old WT mice and *Bmi1*^-/-^ mice (Fig. [2](#F2){ref-type="fig"}D). The results showed that a decrease in primordial and primary follicles from 1 to 7-week-old WT mice was accompanied by a dramatic decline in *Bmi1*^-/-^ mice at the same age (Figs. [2](#F2){ref-type="fig"}E-F). We also found the numbers of secondary and mature follicles increased from 4 to 7-week-old WT mice; however, their numbers were dramatically reduced in *Bmi1*^-/-^mice at the same age (Figs. [2](#F2){ref-type="fig"}G-H). In addition, the number of atretic follicles increased notably in 7-week-old *Bmi1*^-/-^mice compared with that in age-matched WT mice (Figs. [2](#F2){ref-type="fig"}I). Collectively, the data suggested that BMI1 deficiency led to defective ovarian and follicle development.

BMI1 deficiency causes oxidative stress status and antioxidant capacity decline in ovaries
------------------------------------------------------------------------------------------

To evaluate whether mice lacking BMI1 undergo oxidative stress in their ovaries, first, we detected the mitochondrial contents and structure in oocytes and granulosa cells using TEM and Mito- tracker. In the WT mice, the mitochondrial outer membrane was smooth and clear, with the mitochondria cristae being clearly visible and in good order. In the *Bmi1*^-/-^ mice, the mitochondrial outer membrane was indistinct and imperfect, with some crest mitochondria blurring or even swelling, and the number of mitochondria was reduced (Figs. [3](#F3){ref-type="fig"}A, 3D). We then detected the changes in ROS levels in 7-week-old *Bmi1*^-/-^ mice and WT mice using flow cytometry analysis. The results revealed increased ROS levels in the ovaries of *Bmi1*^-/-^ mice compared with those in WT mice (Figs. [3](#F3){ref-type="fig"}B-C). To explore whether the levels of various antioxidant proteins was related to BMI1 deficiency, we preformed real-time RT-PCR and western blotting. These results indicated that the mRNA levels of *Sod1*, *Sod2*, *Gpx1*, *Cat*, and *Gsr* and the protein levels of SOD1 and SOD2 in ovaries were downregulated markedly in *Bmi1^-/-^*mice compared with those in WT mice (Figs. [3](#F3){ref-type="fig"}E-H). As shown in Fig. [3](#F3){ref-type="fig"}I, we sought to assess whether oxidative stress in ovaries increased DNA damage using immunohistochemistry for 8-OHdG and γ.H2A.X. We observed a significant increase in cells positive for 8-OHdG and γ.H2A.X in *Bmi1^-/-^*mice compared with that in WT mice (Fig. [3](#F3){ref-type="fig"}J-K).

BMI1 deficiency reduces proliferation and induces apoptosis of granulosa cells by activating the p16/p19 signaling pathway in ovaries
-------------------------------------------------------------------------------------------------------------------------------------

Granulosa cells are essential to regulate follicular development, so the large atretic follicles caused by deletion of *Bmi1* were assumed to be related to granulosa cells. The proliferation and apoptosis of granulosa cells were examined in 7-week-old mice (Fig. [4](#F4){ref-type="fig"}A). As expected, the percentage of PCNA-positive cells was significantly reduced in *Bmi1*^-/-^ mice (Fig. [4](#F4){ref-type="fig"}C) and the percentage of Caspase-3-positive cells increased (Fig. [4](#F4){ref-type="fig"}D). To identify whether the changes in granulosa cells caused by BMI1 deficiency were related to activation of the p16 and p19 pathways in ovaries, the expression levels of p16 and p19 pathway-associated molecules were measured (Fig. [4](#F4){ref-type="fig"}B). We observed that the relative protein expression levels were upregulated markedly in the *Bmi1*^-/-^mice (Fig. [4](#F4){ref-type="fig"}F-H). Coincident with this upregulation, there was a marked decrease in the level of anti-apoptotic protein BCL-2 in the *Bmi1*^-/-^mice (Fig. [4](#F4){ref-type="fig"}E).

NAC supplementation improves ovarian and follicular developmental defects caused by BMI1 deficiency
---------------------------------------------------------------------------------------------------

To determine whether NAC supplementation could improve defective ovarian and follicle development in *Bmi1^-/-^*mice, 3-week-old *Bmi1^-/-^* mice were given NAC in their drinking water until they were 7 weeks old and the phenotypes of the ovaries were examined. The results showed that the ovarian size, weight, and body weight ratio increased markedly in NAC-treated *Bmi1^-/-^*mice compared with that in vehicle-treated *Bmi1^-/-^*mice (Fig. [5](#F5){ref-type="fig"}A-C). In contrast to that in untreated *Bmi1^-/-^* mice, the number of primordial and primary follicles observed in the antioxidant-treated *Bmi1*^-/-^ mice increased insignificantly (Fig. [5](#F5){ref-type="fig"}E-F). In addition, a significant increase in the number of secondary and mature follicles was observed (Fig. [5](#F5){ref-type="fig"}G-H). The number of atretic follicles decreased dramatically in the NAC-treated *Bmi1^-/-^*mice (Fig. [5](#F5){ref-type="fig"}I).

NAC supplementation inhibits oxidative stress, DNA damage, and cellular apoptosis, and stimulates cellular proliferation
------------------------------------------------------------------------------------------------------------------------

To evaluate whether the improvements in ovarian and follicular development induced by NAC supplementation were associated with inhibiting oxidative stress, DNA damage, and cellular apoptosis, and stimulating cellular proliferation, in *Bmi1*^-/-^ mice, we assessed any alterations in ROS levels, protein expression levels of anti-oxidative enzymes in ovaries, DNA damage, cellular apoptosis, and proliferation in 7-week-old mice. The ROS levels were notably decreased in NAC-treated *Bmi1^-/-^*mice compared with those in *Bmi1^-/-^* mice (Fig. [6](#F6){ref-type="fig"}A), and the protein levels of SOD1 and SOD2 were also upregulated significantly. Overall, the parameters increased notably in NAC-treated *Bmi1^-/-^*mice compared with untreated *Bmi1^-/-^*mice (Figs. [6](#F6){ref-type="fig"}B-D). A similar result was noted for the increased level of 8-OHdG, γ.H2A.X and Caspase-3, positive cells in *Bmi1*^-/-^ mice compared with WT mice, and fewer BrdU-positive cells were noted in mice lacking BMI1 (Figs. [6](#F6){ref-type="fig"}E-I). Most, but not all, of these parameters could be rescued by NAC administration (Figs. [6](#F6){ref-type="fig"}A-I).

NAC supplementation ameliorates the developmental potential of early embryos from *Bmi1*^-/-^ mice
--------------------------------------------------------------------------------------------------

Next, we investigated whether NAC supplementation could promote the developmental competence of subsequent embryos. To address this question, we performed *in vitro* fertilization (IVF) of oocytes from WT mice, vehicle-treated *Bmi*1*^-/-^*mice, and NAC-treated *Bmi1^-/-^*mice. The embryos were then cultured to check their development. We noticed that fewer oocytes derived from ovaries in the vehicle-treated *Bmi1^-/-^*mice compared with that in WT mice; however, the number of oocytes increased significantly in the NAC-treated *Bmi1^-/-^*mice, although they did not reach the WT mouse levels (Fig. [7](#F7){ref-type="fig"}B). Oocytes derived from WT mice with IVF could develop into early embryos, including 2-cells, 4-cells, and blastocysts in *in vitro* cultures (Figs. [7](#F7){ref-type="fig"}A, C); however, oocytes derived from *Bmi1*^-/-^ mice treated with IVF did not developed into early embryos, even 2-cell stage embryos. Surprisingly, oocytes derived from NAC-treated *Bmi1^-/-^*mice with IVF developed into early embryos, including 2-cells, 4-cells, and blastocysts in*in vitro* culture, which approached the level of the WT mice (Figs. [7](#F7){ref-type="fig"}A, C). These observations demonstrated that the compromised developmental potential of early embryos from*Bmi1^-/-^*mice could be partially rescued by the antioxidant NAC.

Discussion
==========

In the present study, we found that BMI1 is expressed in follicular granulosa cells, follicular cells, and mesenchymal cells, which suggested that mice lacking BMI1 might have female reproduction defects. The effect of BMI1 was studied using a mouse model with the homozygous deletion of *Bmi1*. *Bmi1* knockout female mice exhibited complete infertility, with ovarian and follicular developmental defects and estrous cycle dysfunction. Oocytes derived from *Bmi1*^-/-^ mice could not develop into embryos *in vitro*, as demonstrated through IVF and embryo culture. Mechanistically, cells lacking BMI1 showed inhibited granulosa cell proliferation, induction of granulosa cell apoptosis, and female infertility by increasing oxidative stress and ongoing DNA damage, triggering the p16/p19 signaling pathway. Furthermore, supplementation with the antioxidant NAC not only improved the reproductive defects caused by *Bmi1* deletion *in vivo*, but also rescued the potential of BMI1-deficient oocytes to develop into embryos.

BMI1 deficiency causes a generalized failure-to- thrive and a significant shortening of lifespan [@B21], [@B22]. In the present study, we found that compared with WT mice, the ovaries were smaller, the numbers of follicles at all stags decreased dramatically, and a large number of atresia appeared in *Bmi1*^-/-^ female mice (Fig. [2](#F2){ref-type="fig"}). Previous studies demonstrated that BMI1 deficiency increased the level of testicular oxidative stress in male mice, and resulted in DNA damage in germ cells [@B19]. In this study, we found the relative ROS relative levels in the ovaries increased significantly in *Bmi1*^-/-^ female mice. Meanwhile, levels antioxidant enzymes, including SOD1, SOD2, GPX1, CAT, GSR, and TXNRD were downregulated markedly. These data revealed that BMI1 deficiency led to oxidative stress. The decreased content of mito-tracker suggested damage to ovarian mitochondria in the *Bmi1*^-/-^ female mice; indeed, TEM revealed an indistinct outer mitochondrial membrane. Mitochondria are the cellular energy factory, and except for the nucleus, they are the only organelle carrying DNA [@B23], [@B24]. The reduced number of mitochondria could result in a lower ATP level, which would activate the mammalian target of rapamycin (mTOR) signaling pathway, and result in abnormal activation, the loss of more follicles, prematurely depleted follicles, and a decline in the ovarian reserve (DOR) [@B25]. Moreover, the available evidence indicates that oxidative stress can cause DNA damage [@B11], which could lead to several cell responses, including inhibiting intracellular signal transduction, gene transcription, and DNA repair; delay or blockage of the cell cycle; induction of cell apoptosis; and the development of tumors [@B26]-[@B28]. DNA double-strand breaks are one type of DNA damage, and phosphorylation of H2A.X is a timely response of eukaryotic cells to DNA double-strand breaks [@B29], [@B30]. 8-OHdG is a good target for oxidative stress-induced DNA damage [@B31]. In this study, we found that there were large increases in γ-H2AX and 8-OHdG positive cells in *Bmi1*^-/-^ female mice (Fig. [3](#F3){ref-type="fig"}). Consequently, increased oxidative stress induced by BMI1 deficiency may be related to mitochondria dysfunction and DNA damage, which could further damage female reproductive function.

PCNA is a proliferative nuclear antigen, and caspase-3 is a critical downstream factor that causes apoptosis directly [@B32], [@B33]. Therefore, we measured these two factors. The number of PCNA positive cells in ovaries decreased, while the number of caspase-3 positive granulosa cells increased dramatically. In addition, the amount of apoptosis inhibitory protein BCL-2 also decreased significantly. The results showed that BMI1 deficiency could reduce proliferation and increase apoptosis, thus accelerating ovarian aging. The above molecular alterations were consistent with the results of previous studies. Moreover, we examined the levels of the anti-oncogenes p16, p19, and p53 by western blotting, and all of them were upregulated significantly in *Bmi1*^-/-^ female mice (Fig. [4](#F4){ref-type="fig"}). As previously reported, BMI1 mainly works by inhibiting Ink4a/Arf transcription, which encodes the cell cycle regulators p16 (Ink4a) and p19 (Arf) [@B1]. Therefore, BMI1 deficiency may result in high levels of p16Ink4a transcription, which would suppress cell cycle processes and break the p16Ink4a balance [@B34]. Besides, the p19Arf/p53 pathway contributes to the progression of cell apoptosis, and is an essential signaling pathway [@B35]. There is evidence that p19Arf and p53 expression increased in neurons from BMI1 deficient mice [@B36]. That study also suggested that p53 is involved in the majority of apoptotic phenotypes [@B36]. In addition, a study showed that inhibiting the expression of p53 could attenuate apoptosis of granulosa cells and the number of atretic follicles [@B37], which correspond with the results of the present study. Thus, BMI1 deficiency can induce apoptosis of oocytes and granulosa cells by activating the p16-Rb and p19-p53 pathways.

NAC, as an endogenous antioxidant, is involved in the decomposition of peroxides by balancing oxidative stress via replenishing intracellular glutathione stores [@B38]. NAC treatment downregulated conjunctival epithelial cell dysfunction by inhibiting ROS production [@B39]. Clinically, NAC has been used to treat lung injury patients with chronic obstructive pulmonary disease, and has the advantage of clearing ROS [@B40], [@B41]. Previous data demonstrated that oxidative stress causes a reduction in the number and quality of oocytes, and upregulation of indicators of cell ageing. The administration of NAC improved the quantity and quality of oocytes, and significantly promoted follicular development [@B12]. In addition, NAC supplementation slowed organ aging and extended lifespan after drinking water containing NAC was administered to *Bmi1*^-/-^ mice [@B42].

To determine whether oxidative stress plays a crucial role on female infertility induced by BMI1 deficiency, the *Bmi1*^-/-^ mice were treated with drinking water containing NAC for 4 weeks. In contrast to untreated *Bmi1*^-/-^ mice, NAC treatment reduced the ROS levels in the ovary, enhanced the antioxidative capacity, decreased DNA damage, and alleviated the obstacle to follicle growth (Fig. [5](#F5){ref-type="fig"}-[6](#F6){ref-type="fig"}). Furthermore, we demonstrated that female infertility induced by BMI1 deficiency could be largely rescued by antioxidant supplement (Fig. [7](#F7){ref-type="fig"}). *Bmi1*^-/-^ female mice are totally infertile; however, the developmental defects of early embryos in *Bmi1*^-/-^ mice were markedly rescued by NAC administration. In addition the average member of retrieved oocytes increased significantly. Nevertheless, there is a limitation: The results for embryo development may be discrepant because of the low fertility of *Bmi1*^-/-^ mice (n = 150 for the WT, n = 8 for *Bmi1*^-/-^, n = 111 for *Bmi1*^-/-^+NAC). Also, the exact mechanism by which antioxidants regulate these molecules remains to be investigated.

Our results implied that BMI1 deficiency results in female infertility with increased ROS production and ongoing DNA damage, whereas these alterations were largely rescued by NAC administration. These results indicated that BMI1 has a crucial role in promoting follicle growth and early embryo development by scavenging ROS, controlling the balance between cell proliferation and apoptosis, preventing DNA damage, and restraining p16Ink4a/ Rb and p19Afr/p53 signaling pathways, which are involved in cell cycle regulation.
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![**The localization of Bmi1 in ovarian and the effects of BMI1 deficiency on the fertility and estrous cycle.** (A) and (B) Bmi1 immunohistochemical staining from 7-week old WT and *Bmi1*^-/-^ female mice. (A) Green arrow: cumulus cell. (Aa) Yellow arrow: granulosa cell. (Aa) Blue arrow: theca cell. (Ab) Red arrows: mesenchymal cells. Scale bar: 50 µm. (C) Five-week old *Bmi1*^-/-^ and WT female mice were mated with WT male mice and checked for the number of littermates after 5 weeks. (D) The result of multiple ovulation from 3-week old WT and *Bmi1*^-/-^ female mice. (E) Statistical result for vaginal opening time. (F) and (I) are estrous cycles of WT and *Bmi1*^-/-^ female mice. (G) The percentage of time at proestrus per 5 days. (H) The percentage of time at estrus per 5 days. (J) The percentage of time at diestrus per 5 days. (K) The percentage of time at metestrus per 5 days. Each value is the mean ± SEM of determinations in five mice of each group. \*: p \< 0.05; \*\*: p \< 0.01; \*\*\*: p \< 0.001 compared with WT mice. Bmi1, B lymphoma Mo-MLV insertion region 1; WT, wild-type; SEM; standard error of the mean.](ijbsv15p0870g001){#F1}

![**BMI1 deficiency results in ovarian and follicular development defects in mice.** (A) Ovarian size and (B) weight from 7-week old mice, (C) ovarian weight/body weight ratio. (D) Representative images of ovarian sections from 1-week, 4-week, and 7-week-old WT and *Bmi1*^-/-^ mice. Scale bar: 100 µm. Yellow arrow: atretic follicle. (E-I) The proportion of each stage follicles in WT mice and *Bmi1*^-/-^ mice. Each value is the mean ± SEM of determinations in five mice of each group. \*: p \< 0.05; \*\*: p \< 0.01; \*\*\*: p \< 0.001 compared with WT mice. Bmi1, B lymphoma Mo-MLV insertion region 1; WT, wild-type; SEM; standard error of the mean.](ijbsv15p0870g002){#F2}

![**BMI1 deficiency causes oxidative stress status and antioxidant capacity decline in ovaries.** (A) TEM images of granulosa cells and oocytes in WT mice and *Bmi1*^-/-^ mice. Scale bar: 500 nm. (B) Representative graphs of flow cytometry analysis of granulosa cells for DCFDA and (C) the statistical result. (D) The mitochondrial morphology in ovarian sections was detected using Mito-tracker probes with FCM. (E) Real-time reverse transcription (RT)-PCR analysis of ovarian extracts from 7-week old mice for expressions of *Sod1*, *Sod2*, *Gpx1*, *Gsr*, *Ca*t, and *Txnrd1*. The mRNA expression levels were determined using real-time reverse transcription (RT)-PCR is calculated as a ratio relative to *Gapdh* expression, and expressed relative to that in WT mice. (F) Western blotting showing the expression of SOD1 and SOD2 in 7-week old mice. (G) SOD1 and (H) SOD2 protein relative levels assessed by densitometry analysis calculated as a ratio relative to β-actin protein levels and expressed relative to their levels in WT mice. (I) Representative micrographs of ovarian sections from 7-week old mice stained immunohistochemically for γ-H2A.X and 8-OHdG. Scale bar: 100 µm. Percentages of (J) γ-H2A.X and (K) 8-OHdG positive cells in mouse ovaries. Each value is the mean ± SEM of determinations in 5 mice of each group. \*: p \< 0.05; \*\*: p \< 0.01 compared with WT mice. Bmi1, B lymphoma Mo-MLV insertion region 1; WT, wild-type; SEM; standard error of the mean; TEM, transmission electron microscopy; DCFDA, diacetyldichlorofluorescein; FCM, flow cytometry; Sod1, superoxide dismutase 1; Sod2, superoxide dismutase 2; Gpx1, glutathione peroxidase 1; Gsr, glutathione-disulfide reductase; Cat, catalase; Txnrd1, thioredoxin reductase 1; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; γ-H2A.X, phosphorylated H2A histone family member X; 8-OHdG, 8-Oxo-2\'-deoxyguanosine.](ijbsv15p0870g003){#F3}

![**BMI1 deficiency reduces the proliferation and induces apoptosis of granulosa cells by activating p16/p19 signaling pathways in ovaries.** (A) Representative micrographs of ovarian sections from 7-week old mice stained immunohistochemically for PCNA and Caspase-3. Percentages of (C) PCNA and (D) Caspase-3 positive cells. Scale bar: 100 µm. (B) Western blotting showing the levels of Caspase-3, BCL-2, p16, p19, and p53. (E) BCL-2, (F) p16, (G) p19 and (H) p53 relative protein levels were assessed by densitometry analysis, calculated as relative to β-actin protein levels and expressed relative to levels in the WT mice. Each value is the mean ± SEM of determinations in five mice of each group. \*\*: p \< 0.01; \*\*\*: p \< 0.001 compared with WT mice. Bmi1, B lymphoma Mo-MLV insertion region 1; WT, wild-type; SEM; standard error of the mean; PCNA, proliferating cell nuclear antigen; Bcl-2, B-cell CLL/lymphoma 2; cyclin dependent kinase inhibitor 2A, p16; cyclin dependent kinase inhibitor 2D, p19; tumor protein p53, p53.](ijbsv15p0870g004){#F4}

![**NAC supplementation improves ovarian and follicular developmental defects caused by BMI1 deficiency.** (A) Ovarian size and (B) weight from 7-week old WT, *Bmi1*^-/-^, Bmi1^-/-^+NAC mice, (C) ovarian weight/body weight ratio. (D) Representative micrographs of ovarian sections from 7-week old mice. Scale bar: 100 µm. (E-I) The proportion of each stage follicles in mice. Each value is the mean ± SEM of determinations in five mice of each group. \*: p \< 0.05; \*\*: p \< 0.01 compared with WT mice. \#: p \< 0.05; \#\#: p \< 0.01 compared with *Bmi1*^-/-^ mice. Bmi1, B lymphoma Mo-MLV insertion region 1; WT, wild-type; SEM; standard error of the mean; NAC, N-acetylcysteine.](ijbsv15p0870g005){#F5}

![**NAC supplementation inhibits oxidative stress, DNA damage and cellular apoptosis, stimulates cellular proliferation.** (A) Representative graphs of flow cytometry analysis of granulosa cells from 7-week-old mice stained for DCFDA. (B) Western blotting showing the expression of SOD1 and SOD2 in WT, vehicle *Bmi1*^-/-^, and *Bmi1*^-/-^+NAC mice. (C) SOD2 and (D) SOD1 relative protein levels assessed by densitometry analysis, calculated as a ratio relative to β-actin protein levels and expressed relative to the levels in WT mice. (E) Representative micrographs of ovarian sections from 7-week old mice stained immunohistochemically for 8-OHdG, γ-H2A.X, Caspase-3, and BrdU. Percentages of (F) 8-OHdG, (G) γ-H2A.X, (H) Caspase-3 and (I) BrdU positive cells in the ovaries. Scale bar: 100 µm. Each value is the mean ± SEM of determinations in five mice of each group. \*: p \< 0.05; \*\*: p \< 0.01; \*\*\*: p \< 0.001 compared with WT mice. \#\#: p \< 0.01 compared with *Bmi1*^-/-^ mice. Bmi1, B lymphoma Mo-MLV insertion region 1; WT, wild-type; SEM; standard error of the mean; NAC, N-acetylcysteine; DCFDA, diacetyldichlorofluorescein; Sod1, superoxide dismutase 1; Sod2, superoxide dismutase 2; γ-H2A.X, phosphorylated H2A histone family member X; 8-OHdG, 8-Oxo-2\'-deoxyguanosine; BrdU, bromodeoxyuridine.](ijbsv15p0870g006){#F6}

![**NAC supplementation ameliorates the developmental potential of early embryos from *Bmi1*^-/-^ mice.** (A) Representative phase contrast images of 2-cell, 4-cell, and blastocyst embryos derived from WT and *Bmi1*^-/-^ oocytes. Scale bar: 200 µm. (B) Number of retrieved oocytes from the three groups. (n = 150 for WT, n = 8 for *Bmi1*^-/-^, n = 111 for *Bmi1*^-/-^+NAC). (C) The percentage of embryos that successfully progressed to the blastocyst stage during *in vitro* culture. Each value is the mean ± SEM of the determinations in three independent experiments. \*: p \< 0.05; \*\*: p \< 0.01 compared with WT mice. \#: p \< 0.05 compared with *Bmi1*^-/-^ mice. Bmi1, B lymphoma Mo-MLV insertion region 1; WT, wild-type; SEM; standard error of the mean; NAC, N-acetylcysteine.](ijbsv15p0870g007){#F7}
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